Atara Biotherapeutics Eulerpool News

Atara Biotherapeutics Aktie News

Atara Biotherapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Atara Biotherapeutics News stellen wir hier zusammen.

• 4. September ·

  Yahoo
  Atara Biotherapeutics Announces Changes to Its Board of Directors
• 19. August ·

  Yahoo
  In cell therapy, cost is a hot issue. The industry might need a cold solution.
• 11. August ·

  Yahoo
  Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
• 24. Juli ·

  Yahoo
  Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
• 7. März ·

  Yahoo
  Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress
• 7. Februar ·

  Yahoo
  Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 21. Januar ·

  Yahoo
  FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
• 21. Januar ·

  Yahoo
  Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219
• 21. Januar ·

  SeekingAlpha
  Atara Biotherapeutics: Another Dip Buying Opportunity Following CRL For CMC Issues
• 16. Januar ·

  Yahoo
  Atara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO Application